Home/Filings/4/0001209191-13-002940
4//SEC Filing

Hemmi Gregory 4

Accession 0001209191-13-002940

CIK 0000949699other

Filed

Jan 10, 7:00 PM ET

Accepted

Jan 11, 7:30 PM ET

Size

16.0 KB

Accession

0001209191-13-002940

Insider Transaction Report

Form 4
Period: 2013-01-11
Hemmi Gregory
VP Chemical Operations
Transactions
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-01-113,04771,953 total
    Exercise: $2.76From: 2007-03-13Exp: 2017-03-13Common Stock (3,047 underlying)
  • Exercise/Conversion

    Common Stock

    2013-01-11$4.16/sh+1,415$5,88624,945 total
  • Sale

    Common Stock

    2013-01-11$67.11/sh5,000$335,55022,992 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-01-115387,462 total
    Exercise: $7.76From: 2005-06-03Exp: 2015-06-03Common Stock (538 underlying)
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2013-01-111,41583,585 total
    Exercise: $4.16From: 2006-05-23Exp: 2016-05-23Commonn Stock (1,415 underlying)
  • Exercise/Conversion

    Common Stock

    2013-01-11$7.76/sh+538$4,17523,530 total
  • Exercise/Conversion

    Common Stock

    2013-01-11$2.76/sh+3,047$8,41027,992 total
Footnotes (1)
  • [F1]Option granted under the issuer's 2004 Equity Incentive Award Plan in a transaction exempt under rule 16b-3(d). The option vests in forty-eight (48) equal and successive monthly installments.

Issuer

PHARMACYCLICS INC

CIK 0000949699

Entity typeother

Related Parties

1
  • filerCIK 0001507649

Filing Metadata

Form type
4
Filed
Jan 10, 7:00 PM ET
Accepted
Jan 11, 7:30 PM ET
Size
16.0 KB